Nanobiotix SA - ADRNBTX
13F holders, Q2 2025 (June 30)10holders −2
2new positions
4sold out
$4.53avg. 13F price*
At the end of Q2 2025, 10 institutions reported holding Nanobiotix SA - ADR (NBTX) in their 13F filings, down 2 from Q1 2025. 2 opened new positions and 4 sold out. The largest holders were Johnson & Johnson ($25.5M), Geode Capital Management, LLC ($48K) and Morgan Stanley ($25K).
- Company
- Nanobiotix SA - ADR
- CUSIP
- 63009J107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $3K |
| Exits | 4 | $420K |
All 13F filers, Q1 2025 → Q2 2025: 2,048 shares bought and 118,198 shares sold, net −116,150 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Johnson & Johnson | 7.62% | No change | 5,623,816 | $25.5M |
| Geode Capital Management, LLC | 0.00% | No change | 10,184 | $48K |
| Morgan Stanley | 0.00% | Reduce -13.1% | 5,300 | $25K |
| UBS Group AG | 0.00% | Add +47.3% | 4,418 | $21K |
| BNP Paribas Financial Markets | 0.00% | Add +15.1% | 761 | $4K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 517 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -8.1% | 125 | $1K |
| Rhumbline Advisers | 0.00% | No change | 33 | $156 |
| National Bank of Canada | 0.00% | New | 13 | $61 |
| Barclays PLC | 0.00% | No change | 4 | $19 |
"% of holder's portfolio" is NBTX's weight in each manager's 13F, not the share of Nanobiotix SA - ADR the manager owns.